InDex Pharmaceuticals Holding AB (publ)

OM:INDEX Stock Report

Market Cap: SEK 286.6m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

InDex Pharmaceuticals Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INDEX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies17,000,0003.19%
Individual Insiders17,100,6283.21%
VC/PE Firms119,651,12522.5%
General Public181,274,90334%
Institutions197,660,99437.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 65.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
Linc AB
69,920,567SEK 37.6m0%1.52%
9.82%
Fourth Swedish National Pension Fund (AP4)
52,314,074SEK 28.1m0%0.01%
9.34%
HBM Partners Ltd.
49,730,558SEK 26.8m0%0.27%
4.67%
Avanza Fonder AB
24,883,601SEK 13.4m0%0.03%
4.67%
Handelsbanken Asset Management
24,872,696SEK 13.4m0%no data
3.58%
SEB-stiftelsen,Endowment Arm
19,047,617SEK 10.2m0%3.95%
3.54%
SEB Venture Capital
18,857,684SEK 10.1m0%11.19%
2.59%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
13,811,812SEK 7.4m0%0.12%
2.42%
Industrifonden
12,865,296SEK 6.9m0%1.0%
2.29%
Swedbank Robur Fonder AB
12,201,330SEK 6.6m0%no data
1.95%
Staffan Rasjo
10,363,353SEK 5.6m0%no data
1.88%
S-E-Bankens Utvecklingsstiftelse
10,000,000SEK 5.4m0%no data
1.31%
Originat AB
7,000,000SEK 3.8m0%no data
1.31%
Ulti AB, Asset Management Arm
7,000,000SEK 3.8m0%no data
1.16%
Ponderus Invest Ab, Asset Management Arm
6,200,000SEK 3.3m0%33.03%
1.05%
Försäkringsbolaget Skandia, Asset Management Arm
5,606,884SEK 3.0m0%no data
0.87%
Edward Thornberg
4,620,544SEK 2.5m0%no data
0.14%
Wenche Rolfsen
755,744SEK 406.6k0%no data
0.081%
Lennart Hansson
432,000SEK 232.4k0%no data
0.077%
Uli Hacksell
408,000SEK 219.5k0%no data
0.073%
Johan Gileus
390,000SEK 209.8k0%no data
0.023%
Jenny Sundqvist
121,951SEK 65.6k0%no data
0.0017%
Charlotte Admyre
9,036SEK 4.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/10 00:22
End of Day Share Price 2024/06/10 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InDex Pharmaceuticals Holding AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Arvid NecanderCarnegie Investment Bank AB
Filip EinarssonRedeye